RTTR

Ritter Pharmaceuticals (RTTR)

Ritter Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RTTR

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2017/06/10	05 : 25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/06/07	04 : 58	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/19	04 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/13	05 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/11	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/09	20 : 26	Marketwired	Ritter Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Updates	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/09	20 : 20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/09	20 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/09	20 : 12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/05/03	01 : 45	GlobeNewswire Inc.	Ritter Pharmaceuticals Announces Issuance of New Patents for its Lactose Intolerance Treatment, RP-G28, and Provides an Updat...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/04/21	19 : 21	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/04/21	19 : 17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/04/12	23 : 00	Marketwired	Ritter Pharmaceuticals, Inc. Announces End of Phase 2 Meeting with the FDA and Initiates Phase 3 Program Development Activiti...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/03/30	04 : 44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/03/29	07 : 28	Marketwired	Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benef...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/03/14	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/28	03 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/27	23 : 00	Marketwired	Ritter Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/27	20 : 16	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/16	07 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/16	07 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/15	07 : 58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/15	04 : 30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/14	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/14	07 : 15	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/13	23 : 00	Marketwired	Ritter Pharmaceuticals Announces Collaboration with University of British Columbia to Explore Development of Microbiome Thera...	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/11	05 : 59	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/10	07 : 04	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/02	05 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc
2017/02/02	05 : 32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:RTTR	Ritter Pharmaceuticals Inc